Episodes 1-4 of 4
Cardiorenal Collaboration: Escape the Treatment Trap
CME/CECardiorenal Collaboration: Escape the Treatment Trap
Plozasiran (ARO-APOC3) Decreases APOC3 and Triglycerides (TG) in Patients With Mixed Hyperlipidemia: MUIR Final Results
MinuteCE®Plozasiran (ARO-APOC3) Decreases APOC3 and Triglycerides (TG) in Patients With Mixed Hyperlipidemia: MUIR Final Results
Main Messages of New ESC Guidelines for CVD Management in Diabetes
Heart MattersMain Messages of New ESC Guidelines for CVD Management in Diabetes